| SpectraBase Spectrum ID |
m9IxL8JZIs |
| Name |
3-(4-Methylbenzoyl)-2-methylindole |
| Classification |
Aroylindole cannabinoid designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
249.115364106 u |
| Formula |
C17H15NO |
| InChI |
InChI=1S/C17H15NO/c1-11-7-9-13(10-8-11)17(19)16-12(2)18-15-6-4-3-5-14(15)16/h3-10,18H,1-2H3 |
| InChIKey |
IABBMFHGQKDLLG-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
249.313 g/mol |
| Nominal Mass |
249 u |
| Quality |
922 |
| Retention Index |
2530 |
| SMILES |
C=1(C=2C(NC1C)=CC=CC2)C(C=1C=CC(=CC1)C)=O |
| SPLASH |
splash10-0002-2690000000-65b0ea7392156b5c12f4 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
2-Methyl-3-(p-toluoyl)indole
(2-Methyl-1H-indol-3-yl)-(4-methylphenyl)methanone |
| Technique |
GC/MS |
| Wiley ID |
DD2024_015399 |
